ALPHA TRIBE

Bacil Pharma LtdUpdates, 06-08-2025: Company Update

06-08-2025 | 11:18 am

Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099

Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541,

Tel/Fax: 22618327

To,

The Manager – Listing Department

BSE Limited

P. J. Towers, Dalal Street,

Mumbai – 400 001

Scrip Code: 524516

Scrip ID: BACPHAR

Subject: Revised Intimation of Resignation of Director

Dear Sir/Madam,

This is in reference to your query regarding our earlier intimation of resignation of Director, wherein it

was observed that the disclosure did not include the names of the listed entities in which the resigning

director holds directorships.

We hereby submit the revised intimation letter, duly incorporating the names of all listed entities

where the resigning director holds directorships, as required under Regulation 30 of the SEBI (Listing

Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No.

CIR/CFD/CMD/4/2015 dated September 09, 2015.

Please find enclosed the revised disclosure in the prescribed format.

We request you to kindly take the same on record.

Thanking you,

For BACIL PHARMA LIMITED

Ms. Chaitali Kalpataru Shah

Director & CFO

DIN: 11167778

Encl.:

SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 (Annexure-1)

Revised intimation letter of resignation of Independent Director (Annexure-2)

Listed entities in which the resigning director holds directorships (Annexure-3)

Shah

Chaitali

Kalpataru

Digitally signed by Shah Chaitali

Kalpataru Date: 2025.08.06

13:20:56 +05'30'

----------------Page (0) Break----------------

Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099

Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541,

Tel/Fax: 22618327

Annexures 1

Sr. No. Details of events Particulars

1 Reason of change viz. appointment,

resignation, removal, death or

otherwise

Mr. Prakash Bhoorchand Shah (DIN:

01136800) as a Director.

2 Date of Appointment/cessation (as

applicable)

Term of Appointment

22nd July, 2025

3 Brief Profile (in case of appointment) Not Applicable

4 Disclosure of relationships between

Directors (in case of appointment of a

Director

Not Applicable

5 Letter of resignation along with

detailed reason for resignation

Enclosed herein as Annexure 2

6 Names of listed entities in which the

resigning director holds Directorships

including the category of Directorship

and Membership of Board

Committees, if any

Enclosed herein as Annexure 3

7 The Director shall along with the

detailed reasons, also provide a

confirmation that there are no other

material reasons other than those

provided.

The required confirmation has been provided

in the resignation letter provided by Mr.

Prakash Bhoorchand Shah (DIN: 01136800)

which is enclosed as Annexure 2.

For BACIL PHARMA LIMITED

Ms. Chaitali Kalpataru Shah

Director & CFO

DIN: 11167778

Shah Chaitali

Kalpataru

Digitally signed by Shah Chaitali Kalpataru

Date: 2025.08.06 13:21:25 +05'30'

----------------Page (1) Break----------------

----------------Page (2) Break----------------

Reg Office: G2 & G3 Samarpan Complex, Next to Mirador Hotel, Chakala, Andheri East, Mumbai – 400099

Email Id: bacilpha@yahoo.com, CIN: L24200MH1987PLC043427, Tel: 22618452/22661541,

Tel/Fax: 22618327

Annexure 3

Sr. no. Name of the listed entities in

which Mr. Prakash

Bhoorchand Shah holds

Directorship

Committee Memberships

in listed entities of Mr.

Prakash Bhoorchand Shah

Designation

1 Sanmitra Commercial Limited Audit Committee

Nomination &

Remuneration Committee &

Policy

Stakeholders Relationship

Committee

Non-Executive

Directors

2 Bacil Pharma Ltd NA Director

For BACIL PHARMA LIMITED

Ms. Chaitali Kalpataru Shah

Director & CFO

DIN: 11167778

Shah

Chaitali

Kalpataru

Digitally signed by Shah Chaitali

Kalpataru Date: 2025.08.06

13:21:55 +05'30'

----------------Page (3) Break----------------

No comments yet. Be the first to comment!

All announcements from Bacil Pharma Ltd